Novolog (Pharm-Up 1966) Ltd

ILA 78.30As of Sun 8 Nov 2026, 12:00 UTC
TASE:NVLGHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR (5.26%)
Div yield 5.00%
ROE (0.17%)
Medical Distribution
Beta (5Y) 0.17
PE TTM —
TSR TTM (37.42%)
Mkt cap ILS 400.0M
ROIC (5.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 92
17.82%
(55.41%)
Hold 10|7|4|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
1.19
1.20
1.31
1.25
38.53%
35.39%
32.08%
16.42%
RevenueILS M
23.20
23.62
23.02
23.49
3.71%
3.35%
1.72%
(1.06%)
Peers (US$125.0M)
Cap (US$)
PE
164.4M
13.53x
50.57M
17.75x
123.3M
11.88x
Capital
TTM
5Y
10Y
Leveragex
0.591
0.069
0.057
EBIT/Intx
2.502
0.023
0.027
Own earn%
170.02
(106.92)
(47.17)
Sh yield%
29.82
37.06
33.56
Owners
Insiders/Inst%
0.38
43.47
Short interest%
4.37
SBC / revenue%
1.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
18–25
$1 testx
—
Incr. ROIC%
22